Boku, N., Ryu, M. -., Kato, K., Chung, H. C., Minashi, K., Lee, K. -., Cho, H., Kang, W. K., Komatsu, Y., Tsuda, M., Yamaguchi, K., Hara, H., Fumita, S., Azuma, M., Chen, L. -., & Kang, Y. -. (2019). safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4). Annals of oncology, 30, 250–258. http://access.bl.uk/ark:/81055/vdc_100092358679.0x000039